298 related articles for article (PubMed ID: 15655365)
21. G1 phase: components, conundrums, context.
Moeller SJ; Sheaff RJ
Results Probl Cell Differ; 2006; 42():1-29. PubMed ID: 16903206
[TBL] [Abstract][Full Text] [Related]
22. Control of the G1/S transition.
Reed SI
Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
[TBL] [Abstract][Full Text] [Related]
23. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
24. Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
[TBL] [Abstract][Full Text] [Related]
25. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle.
Lauper N; Beck AR; Cariou S; Richman L; Hofmann K; Reith W; Slingerland JM; Amati B
Oncogene; 1998 Nov; 17(20):2637-43. PubMed ID: 9840927
[TBL] [Abstract][Full Text] [Related]
26. Living with or without cyclins and cyclin-dependent kinases.
Sherr CJ; Roberts JM
Genes Dev; 2004 Nov; 18(22):2699-711. PubMed ID: 15545627
[TBL] [Abstract][Full Text] [Related]
27. The cell cycle kinases.
Pines J
Semin Cancer Biol; 1994 Aug; 5(4):305-13. PubMed ID: 7803767
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of the cell cycle in cancer.
Sandhu C; Slingerland J
Cancer Detect Prev; 2000; 24(2):107-18. PubMed ID: 10917130
[TBL] [Abstract][Full Text] [Related]
29. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
John PC; Mews M; Moore R
Protoplasma; 2001; 216(3-4):119-42. PubMed ID: 11732181
[TBL] [Abstract][Full Text] [Related]
30. [The serine/threonine kinases that control cell cycle progression as therapeutic targets].
Diallo A; Prigent C
Bull Cancer; 2011 Nov; 98(11):1335-45. PubMed ID: 22020767
[TBL] [Abstract][Full Text] [Related]
31. The mammalian cell cycle in normal and abnormal growth.
Orlowski CC; Furlanetto RW
Endocrinol Metab Clin North Am; 1996 Sep; 25(3):491-502. PubMed ID: 8879983
[TBL] [Abstract][Full Text] [Related]
32. Cdks, cyclins and CKIs: roles beyond cell cycle regulation.
Lim S; Kaldis P
Development; 2013 Aug; 140(15):3079-93. PubMed ID: 23861057
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids.
Corroyer S; Nabeyrat E; Clement A
Endocrinology; 1997 Sep; 138(9):3677-85. PubMed ID: 9275052
[TBL] [Abstract][Full Text] [Related]
34. Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3).
Menjo M; Kaneko Y; Ogata E; Ikeda K; Nakanishi M
Oncogene; 1998 Nov; 17(20):2619-27. PubMed ID: 9840925
[TBL] [Abstract][Full Text] [Related]
35. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
Vermeulen K; Van Bockstaele DR; Berneman ZN
Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
[TBL] [Abstract][Full Text] [Related]
36. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB and cell-cycle regulation: the cyclin connection.
Joyce D; Albanese C; Steer J; Fu M; Bouzahzah B; Pestell RG
Cytokine Growth Factor Rev; 2001 Mar; 12(1):73-90. PubMed ID: 11312120
[TBL] [Abstract][Full Text] [Related]
38. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
40. Why minimal is not optimal: driving the mammalian cell cycle--and drug discovery--with a physiologic CDK control network.
Merrick KA; Fisher RP
Cell Cycle; 2012 Jul; 11(14):2600-5. PubMed ID: 22732498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
